First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure - Archive ouverte HAL Access content directly
Journal Articles Antiviral Research Year : 2022

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

(1) , (2) , (3, 4) , (5) , (6) , (7, 8) , (9, 10) , (11, 12) , (1, 13) , (1, 13)
1
2
3
4
5
6
7
8
9
10
11
12
13

Domains

Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Human health and pathology Infectious diseases

Audrey MIRAND  : Connect in order to contact the contributor

https://hal.uca.fr/hal-03851053

Submitted on : Monday, November 14, 2022-11:50:39 AM

Last modification on : Tuesday, November 15, 2022-4:00:24 AM

Not file

Dates and versions

hal-03851053 , version 1 (14-11-2022)

Identifiers

Cite

Clotilde Muller, Valentin Tilloy, Emilie Frobert, Linda Feghoul, Isabelle Garrigue, et al.. First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure. Antiviral Research, 2022, 204, pp.105361. ⟨10.1016/j.antiviral.2022.105361⟩. ⟨hal-03851053⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

ENS-LYON UNILIM PRES_CLERMONT CNRS UNIV-FCOMTE UNIV-LYON1 GEIST CIRI UDL CIRI-B-LINA-M-ROSA-CALATRAVA-VIRPATH OMEGAHEALTH LABCIS
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More